Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The isolation, cloning and identification of a vegetative catalase gene from Bacillus subtilis.
Bol DK, Yasbin RE. Bol DK, et al. Gene. 1991 Dec 20;109(1):31-7. doi: 10.1016/0378-1119(91)90585-y. Gene. 1991. PMID: 1756979
Analysis of the dual regulatory mechanisms controlling expression of the vegetative catalase gene of Bacillus subtilis.
Bol DK, Yasbin RE. Bol DK, et al. J Bacteriol. 1994 Nov;176(21):6744-8. doi: 10.1128/jb.176.21.6744-6748.1994. J Bacteriol. 1994. PMID: 7961428 Free PMC article.
Characterization of an inducible oxidative stress system in Bacillus subtilis.
Bol DK, Yasbin RE. Bol DK, et al. J Bacteriol. 1990 Jun;172(6):3503-6. doi: 10.1128/jb.172.6.3503-3506.1990. J Bacteriol. 1990. PMID: 2111811 Free PMC article.
A phase I dose-ranging study of the pharmacokinetics, pharmacodynamics, safety, and tolerability of AVN944, an IMPDH inhibitor, in healthy male volunteers.
Hamilton JM, Harding MW, Genna T, Bol DK. Hamilton JM, et al. Among authors: bol dk. J Clin Pharmacol. 2009 Jan;49(1):30-8. doi: 10.1177/0091270008325149. Epub 2008 Oct 29. J Clin Pharmacol. 2009. PMID: 18971325 Clinical Trial.
Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeutics.
Kellar KA, Lorenzi MV, Ho CP, You D, Wen ML, Ryseck RP, Oppenheimer S, Fink BE, Vite GD, Rowley BR, Yu C, Bol DK, Lee FY, Wong TW. Kellar KA, et al. Among authors: bol dk. Mol Cancer Ther. 2006 Jun;5(6):1571-6. doi: 10.1158/1535-7163.MCT-06-0078. Mol Cancer Ther. 2006. PMID: 16818516 Free article.
Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor.
Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK, Camuso AE, Gottardis M, Greer AF, Ho CP, Hurlburt W, Li A, Saulnier M, Velaparthi U, Wang C, Wen ML, Westhouse RA, Wittman M, Zimmermann K, Rupnow BA, Wong TW. Carboni JM, et al. Among authors: bol dk. Cancer Res. 2005 May 1;65(9):3781-7. doi: 10.1158/0008-5472.CAN-04-4602. Cancer Res. 2005. PMID: 15867374 Free article.
Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.
Feith DJ, Bol DK, Carboni JM, Lynch MJ, Sass-Kuhn S, Shoop PL, Shantz LM. Feith DJ, et al. Among authors: bol dk. Cancer Res. 2005 Jan 15;65(2):572-8. Cancer Res. 2005. PMID: 15695401 Free article.
Apoptotic and cytostatic farnesyltransferase inhibitors have distinct pharmacology and efficacy profiles in tumor models.
Manne V, Lee FY, Bol DK, Gullo-Brown J, Fairchild CR, Lombardo LJ, Smykla RA, Vite GD, Wen ML, Yu C, Wong TW, Hunt JT. Manne V, et al. Among authors: bol dk. Cancer Res. 2004 Jun 1;64(11):3974-80. doi: 10.1158/0008-5472.CAN-03-3849. Cancer Res. 2004. PMID: 15173010 Free article.
Targeted expression of c-Src in epidermal basal cells leads to enhanced skin tumor promotion, malignant progression, and metastasis.
Matsumoto T, Jiang J, Kiguchi K, Ruffino L, Carbajal S, Beltrán L, Bol DK, Rosenberg MP, DiGiovanni J. Matsumoto T, et al. Among authors: bol dk. Cancer Res. 2003 Aug 15;63(16):4819-28. Cancer Res. 2003. PMID: 12941801 Free article.
Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.
Bol DK, Rowley RB, Ho CP, Pilz B, Dell J, Swerdel M, Kiguchi K, Muga S, Klein R, Fischer SM. Bol DK, et al. Cancer Res. 2002 May 1;62(9):2516-21. Cancer Res. 2002. PMID: 11980643 Free article.
15 results
Jump to page